Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.645 | 0.280 | 17 | 39723335 | missense variant | A/G;T | snv | 0.20 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.100 | 0.895 | 38 | 2000 | 2018 | |||||||
|
0.645 | 0.280 | 17 | 39723335 | missense variant | A/G;T | snv | 0.20 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.100 | 0.895 | 38 | 2000 | 2018 | |||||||
|
0.732 | 0.240 | 17 | 39727965 | missense variant | G/A;C;T | snv | 3.2E-05; 2.4E-05; 1.2E-05 |
|
Neoplasms | 0.070 | 1.000 | 7 | 2008 | 2018 | |||||||
|
0.645 | 0.280 | 17 | 39723335 | missense variant | A/G;T | snv | 0.20 |
|
Neoplasms | 0.050 | 0.600 | 5 | 2007 | 2013 | |||||||
|
0.776 | 0.200 | 17 | 39723967 | missense variant | T/C;G | snv |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 5 | 2008 | 2016 | ||||||||
|
1.000 | 17 | 39687906 | stop gained | C/A | snv | 2.1E-05 |
|
Pathological Conditions, Signs and Symptoms; Nervous System Diseases | 0.700 | 1.000 | 5 | 2007 | 2018 | ||||||||
|
1.000 | 17 | 39687906 | stop gained | C/A | snv | 2.1E-05 |
|
0.700 | 1.000 | 5 | 2007 | 2018 | |||||||||
|
1.000 | 17 | 39687906 | stop gained | C/A | snv | 2.1E-05 |
|
Nervous System Diseases | 0.700 | 1.000 | 5 | 2007 | 2018 | ||||||||
|
0.882 | 0.120 | 17 | 39725125 | missense variant | A/G | snv | 7.0E-06 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.700 | 1.000 | 5 | 2004 | 2013 | |||||||
|
0.658 | 0.360 | 17 | 39727784 | missense variant | C/G | snv | 0.61 | 0.52 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.040 | 0.750 | 4 | 2013 | 2017 | ||||||
|
0.658 | 0.360 | 17 | 39727784 | missense variant | C/G | snv | 0.61 | 0.52 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.040 | 0.750 | 4 | 2013 | 2017 | ||||||
|
0.827 | 0.160 | 17 | 39724008 | missense variant | G/A;C;T | snv |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 4 | 2006 | 2016 | ||||||||
|
0.807 | 0.120 | 17 | 39724747 | missense variant | G/A;C;T | snv |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 4 | 2011 | 2016 | ||||||||
|
0.732 | 0.240 | 17 | 39727965 | missense variant | G/A;C;T | snv | 3.2E-05; 2.4E-05; 1.2E-05 |
|
Neoplasms | 0.040 | 0.750 | 4 | 2014 | 2019 | |||||||
|
0.827 | 0.120 | 17 | 39726987 | missense variant | G/A | snv | 8.4E-06 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.040 | 1.000 | 4 | 2008 | 2017 | |||||||
|
0.827 | 0.120 | 17 | 39726987 | missense variant | G/A | snv | 8.4E-06 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.040 | 1.000 | 4 | 2008 | 2017 | |||||||
|
0.790 | 0.160 | 17 | 39725079 | missense variant | G/A | snv | 4.0E-06 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 3 | 2006 | 2016 | |||||||
|
0.645 | 0.280 | 17 | 39723335 | missense variant | A/G;T | snv | 0.20 |
|
Neoplasms | 0.030 | 0.667 | 3 | 2010 | 2019 | |||||||
|
0.645 | 0.280 | 17 | 39723335 | missense variant | A/G;T | snv | 0.20 |
|
Neoplasms | 0.030 | 0.667 | 3 | 2010 | 2019 | |||||||
|
0.827 | 0.160 | 17 | 39724008 | missense variant | G/A;C;T | snv |
|
Neoplasms | 0.030 | 1.000 | 3 | 2015 | 2018 | ||||||||
|
0.776 | 0.200 | 17 | 39723967 | missense variant | T/C;G | snv |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.030 | 1.000 | 3 | 2017 | 2019 | ||||||||
|
0.776 | 0.200 | 17 | 39723967 | missense variant | T/C;G | snv |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.030 | 1.000 | 3 | 2017 | 2019 | ||||||||
|
0.807 | 0.120 | 17 | 39724747 | missense variant | G/A;C;T | snv |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.030 | 1.000 | 3 | 2017 | 2019 | ||||||||
|
0.807 | 0.120 | 17 | 39724747 | missense variant | G/A;C;T | snv |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.030 | 1.000 | 3 | 2017 | 2019 | ||||||||
|
0.807 | 0.120 | 17 | 39724747 | missense variant | G/A;C;T | snv |
|
0.030 | 0.667 | 3 | 2016 | 2017 |